There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears to slow ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to ...

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...

Zahydie Burgos Ribot and her husband Francisco are working on completing their travel bucket list and spending quality time ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

A doctor has urged people to stick to six life-changing habits to help keep dementia at bay, advising that these ...

Symptoms of young-onset dementia have considerable overlap with those common in certain mental health conditions, such as ...

Dementia — the progressive decline in cognitive abilities, impacting memory, language and reasoning — affects more than 6 million Americans and accounts for over 100,000 deaths each year.

HudsonAlpha launched a pilot study, Hope AD, to see how genetics and lifestyle influence a person’s risk of developing ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...